How This Dutch AI Startup Is Quietly Transforming Hearing Care Access

Jan de Vries · 2026-08-28

You know that feeling when you spot a startup that's not just chasing trends, but actually solving a real, human problem? That's the story with Clementine. This Maastricht-based company just landed $2 million in Seed funding to scale something pretty special. They're not building another generic AI chatbot—they've created what they call the world's first AI hearing activation platform, designed specifically for the hearing-care industry. ### The AI Agent Bridging The Gap At the heart of Clementine's platform is Matthew. Think of Matthew as a patient's first point of contact—an AI hearing care agent that's available 24/7. No judgment, no waiting lists, just immediate, compassionate engagement. Here's what makes Matthew different: - He answers questions any time of day - He educates users about hearing care - He helps overcome emotional barriers that keep people from seeking help - He guides prospective patients toward the right clinical care For clinics drowning in administrative work, Matthew translates inquiries into actual bookings. For patients, he creates a safe, pressure-free starting point. ### Why Investors Are Listening Healthy.Capital, an Amsterdam-based HealthTech investor, led this funding round. They've backed other promising health startups like Pharmi and OpenUp, so they know what they're looking for. Douwe Jippes, managing partner at Healthy.Capital, put it perfectly: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with hearing healthcare." That last part is key—they're not just automating conversations; they're changing how an entire industry connects with people who need help. ### The Stark Reality Of Hearing Loss Let's talk numbers for a second, because they're staggering. Hearing loss affects about 1.5 billion people worldwide. But here's the kicker—nearly 80% of those affected never seek treatment. And those who do? They typically wait more than eight years before taking action. Eight years. That's a long time to struggle with something that modern medicine can actually help with. Founder and CEO Vince van de Weijer explained the core problem: "Clinics don't need more leads; they need better conversations at the right moment. Matthew ensures no patient inquiry goes unanswered." ### What's Next For Clementine The timing of this funding is interesting. Clementine just expanded into North America through a partnership with Zoolstra, a marketing agency serving hearing clinics across the United States and Canada. With this new capital, they plan to: - Deepen their AI capabilities - Expand partnerships with hearing clinics - Build relationships with optical retailers and other healthcare organizations - Continue their North American expansion What I find most compelling is their approach. They're pairing AI with behavioral science to meet people where they are—literally and emotionally. Before someone's ready to walk into a clinic, they can have a judgment-free conversation that might finally get them the help they need. It's one of those ideas that makes you think, "Why didn't someone do this sooner?" And now that Clementine has secured this funding, they're positioned to scale that impact far beyond their Dutch roots.